Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 5Radiation Injuries 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Cardiotoxicity 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Rectal Neoplasms 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Locally Advanced Cervical Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Heart Diseases 1Hearing Loss 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Vincristine 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Genetic Association Studies 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ototoxicity × Chemoradiotherapy × Clear all
NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Recruiting
250 enrolled

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡